DERMAPHARM HLDG SE revenue for the last year amounted to 1.05 B CHF, the most of which — 495.14 M CHF — came from its highest performing source at the moment, Branded Medicine. The greatest contribution to the revenue figure was made by Germany — last year it brought DERMAPHARM HLDG SE 656.96 M CHF, and the year before that — 1.01 B CHF.